Company news
Eyebright Medical Technology (beijing) Co., Ltd. Class A (SSE:688050) news
Eyebright Medical Technology (beijing) Co., Ltd. Class A news releases on 6ix. Latest, Sep 10, 2026: "Eyebright Medical Technology (Beijing) Co.…
View Eyebright Medical Technology (beijing) Co., Ltd. Class A →
Press releases & updates
"Eyebright Medical Technology (Beijing) Co., Ltd."Announcement on Signing Quadripartite Supervision Agreement for Deposit of Raised Funds in Special Account
September 9, 2026
"Eyebright Medical Technology (Beijing) Co., Ltd."Special Report on the Deposit, Management and Actual Use of Raised Funds for the First Half of 2026
August 25, 2026
Announcement on Implementation of Dividend Distribution for 2025
June 12, 2026
Announcement on Vesting Results in the 4th Vesting Period of Reserved Grant Portion under the 2021 Restricted Stock Incentive Plan and Stock Listing
May 29, 2026
InnoCare Announces the Acceptance of New Drug Application for Orelabrutinib in Primary Immune Thrombocytopenia in China
May 28, 2026
Announcement on Resignation and By-election of Employee Director
May 21, 2026
Science and Technology for People's Well-being - Achievement of Enterprises on SSE STAR Market and Its Empowerment of People's Livelihood Conference
April 29, 2026
Announcement on the Result of Shareholding Reduction Plan for Shareholder and Equity Change Reaching the 5% Scale
April 27, 2026
Eyebright Medical Releases Its 2025 Annual Report and Sustainability Report
April 26, 2026
Notice on Convening the 2025 Annual General Meeting
April 22, 2026
Announcement on Shareholding Reduction Plan for Shareholders
March 18, 2026
Preliminary Earnings Estimate for 2025
February 27, 2026
Announcement on Acquisition of Partial Equity in Delta United (Chongqing) Medical Technology Co., Ltd.
February 25, 2026
Announcement on Convening the Q3 2025 Performance Briefing
November 20, 2025
Announcement on Circulation of Restricted Shares Issued to Specific Objects by Simplified Procedure
November 4, 2025
Report for Q3 2025
October 29, 2025
Announcement on Voluntary Disclosure of Approval for Market Launch of the Extended Depth-of-Focus Intraocular Lens (EDOF IOL) Through the Special Review Process for Innovative Medical Devices
September 26, 2025
Announcement on the Result of Shareholding Reduction by Shareholder and Equity Change Reaching the 1% Scale
September 4, 2025
Announcement on Convening the 2025 Semi-annual Performance Briefing
August 27, 2025
Indicative Announcement on Change in Equity of Shareholders with Over 5% Shares Reaching 1%
August 7, 2025
Announcement on Implementation of Dividend Distribution for 2024
July 11, 2025
Announcement on Adjusting Total Cash Dividends for 2024 Annual Profit Distribution
June 27, 2025
Announcement on Changing Registered Capital, Amending the Articles of Association, and Handling Industrial and Commercial Change Registration
June 19, 2025
Announcement on Share Reduction Plan for Shareholders
June 3, 2025
Announcement on Cancellation of Some Restricted Stocks Granted yet Unvested in 2021 Restricted Stock Incentive Plan
May 29, 2025
Announcement on Results of Issuing Shares to Specific Objects by Summary Procedure and Changes in Capital Stock in 2024
May 13, 2025
Announcement on Signing Three-party and Four-party Supervision Agreements for Deposit of Raised Fund in Special Account
May 6, 2025
Eyebright Medical Published its 2024 Environmental, Social and Governance Report
April 22, 2025
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
April 16, 2025
Announcement on Approval of Application for Issuance of Shares to Specific Objects via Summary Procedure by the Shanghai Stock Exchange in 2024
March 12, 2025
Announcement on the Expiry of Planned Time for Shareholders with Over 5% Shares to Reduce Shares and Results of Share Reduction
March 10, 2025
Announcement on the Acceptance of Application for Issuance of Shares to Specific Objects via Summary Procedure by the Shanghai Stock Exchange
February 28, 2025
Announcement on Diluted Immediate Return, Remedial Measures, and Related Entity Commitments for Issuance of Shares to Specific Objects by Summary Procedure (Second Revised)
February 25, 2025
Announcement on the Release of Pledge of Shares by Shareholders
February 12, 2025
Announcement on Implementation Results of Share Repurchase
February 6, 2025
Announcement on the Voluntary Disclosure of the Phakic Intraocular Lens Being Approved for Marketing through the Special Review Procedure for Innovative Medical Devices
January 7, 2025
Announcement on Progress in Repurchasing Shares through Call Auction
January 3, 2025
Announcement on the Completion of the Company's Shareholding Increase Plan by Controlling Shareholders, Actual Controllers, Chairman and General Manager, Some Directors, and Senior Management and Results of Shareholding Increase
December 23, 2024
Announcement on Resolution of the 16th Meeting of the 2nd Board of Directors
December 5, 2024
Announcement on Share Reduction Plan for Shareholders with Over 5% Shares
November 18, 2024
Announcement on Convening the Q3 2024 Performance Briefing
November 11, 2024
Report for Q3 2024
October 29, 2024
Announcement on Participating in the 2024 Semi-Annual Special Collective Performance Presentation Meeting for Medical Devices and Medical Equipment in STAR Market
September 5, 2024
Announcement on Release of Pledge of Some Shares of Shareholders
September 2, 2024
Special Report on Semi-annual Deposit and Actual Use of Raised Funds in 2024
August 21, 2024